Literature DB >> 22547015

Liver resection for multiple colorectal liver metastases with surgery up-front approach: bi-institutional analysis of 736 consecutive cases.

Akio Saiura1, Junji Yamamoto, Kiyoshi Hasegawa, Rintaro Koga, Yoshihiro Sakamoto, Shojiro Hata, Masatoshi Makuuchi, Norihiro Kokudo.   

Abstract

BACKGROUND: Preoperative chemotherapy has become more common in the management of multiple resectable colorectal liver metastases; however, the benefit is unclear. This study examined clinical outcomes following liver resection for multiple colorectal liver metastases with the surgery up-front approach.
METHODS: Data collected prospectively over a 16-year period for 736 patients who underwent hepatic resection at two different centers were reviewed. Patients were divided into three groups depending on the number of tumors as follows: group A, between one and three tumors (n = 493); group B, between four and seven tumors (n = 141); and group C, eight or more tumors (n = 102).
RESULTS: The 5-year overall and recurrence-free survival rates were 51 and 21 %, respectively, for the entire patient cohort, 56 and 29 % in group A, 41 and 12 % in group B, and 33 and 1.7 % in group C. Multivariate analysis showed that decreased survival was associated with positive lymph node metastasis of the primary tumor, the presence of extrahepatic tumors, a maximum liver tumor size >5 cm, and tumor exposure during liver resection.
CONCLUSIONS: In patients with multiple liver metastases, the number of liver metastases has less impact on the prognosis than other prognostic factors. Complete resection with repeat metastasectomy offers a chance of cure even in patients with numerous colorectal liver metastases (i.e., those with eight or more nodules). A further prospective study is necessary to clarify the optimal setting of preoperative chemotherapy.

Entities:  

Mesh:

Year:  2012        PMID: 22547015     DOI: 10.1007/s00268-012-1616-y

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  34 in total

1.  Colorectal cancer with synchronous liver metastases.

Authors:  R Adam
Journal:  Br J Surg       Date:  2007-02       Impact factor: 6.939

2.  Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases.

Authors:  Mehdi Karoui; Christophe Penna; Mohamed Amin-Hashem; Emmanuel Mitry; Stephane Benoist; Brigitte Franc; Philippe Rougier; Bernard Nordlinger
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

3.  Trends in long-term survival following liver resection for hepatic colorectal metastases.

Authors:  Michael A Choti; James V Sitzmann; Marcelo F Tiburi; Wuthi Sumetchotimetha; Ram Rangsin; Richard D Schulick; Keith D Lillemoe; Charles J Yeo; John L Cameron
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

4.  Repeat liver resection for recurrent colorectal liver metastases.

Authors:  J Yamamoto; T Kosuge; K Shimada; S Yamasaki; Y Moriya; K Sugihara
Journal:  Am J Surg       Date:  1999-10       Impact factor: 2.565

5.  Repeat hepatectomy for recurrent colorectal liver metastases.

Authors:  Patrick Pessaux; Emilie Lermite; Olivier Brehant; Jean-Jacques Tuech; Gérard Lorimier; Jean-Pierre Arnaud
Journal:  J Surg Oncol       Date:  2006-01-01       Impact factor: 3.454

Review 6.  Metastatic liver tumors.

Authors:  M D McCarter; Y Fong
Journal:  Semin Surg Oncol       Date:  2000 Sep-Oct

7.  Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients.

Authors:  Myrddin Rees; Paris P Tekkis; Fenella K S Welsh; Thomas O'Rourke; Timothy G John
Journal:  Ann Surg       Date:  2008-01       Impact factor: 12.969

8.  R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?

Authors:  Robbert J de Haas; Dennis A Wicherts; Eduardo Flores; Daniel Azoulay; Denis Castaing; René Adam
Journal:  Ann Surg       Date:  2008-10       Impact factor: 12.969

Review 9.  Expanding criteria for resectability of colorectal liver metastases.

Authors:  Timothy M Pawlik; Richard D Schulick; Michael A Choti
Journal:  Oncologist       Date:  2008-01

10.  One-stage ultrasonographically guided hepatectomy for multiple bilobar colorectal metastases: a feasible and effective alternative to the 2-stage approach.

Authors:  Guido Torzilli; Fabio Procopio; Florin Botea; Matteo Marconi; Daniele Del Fabbro; Matteo Donadon; Angela Palmisano; Antonino Spinelli; Marco Montorsi
Journal:  Surgery       Date:  2009-07       Impact factor: 3.982

View more
  13 in total

Review 1.  Role of cetuximab in first-line treatment of metastatic colorectal cancer.

Authors:  Miguel Jhonatan Sotelo; Beatriz García-Paredes; Carlos Aguado; Javier Sastre; Eduardo Díaz-Rubio
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

2.  R1 Resection for Colorectal Liver Metastases: a Survey Questioning Surgeons about Its Incidence, Clinical Impact, and Management.

Authors:  Luca Viganò; Guido Costa; Matteo Maria Cimino; Fabio Procopio; Matteo Donadon; Daniele Del Fabbro; Jacques Belghiti; Norihiro Kokudo; Masatoshi Makuuchi; Jean-Nicolas Vauthey; Guido Torzilli
Journal:  J Gastrointest Surg       Date:  2018-06-08       Impact factor: 3.452

3.  Risk Factors for Unresectable Recurrence After Up-Front Surgery for Colorectal Liver Metastasis.

Authors:  Daisuke Hokuto; Takeo Nomi; Satoshi Yasuda; Takahiro Yoshikawa; Kohei Ishioka; Takatsugu Yamada; Takahiro Akahori; Kenji Nakagawa; Minako Nagai; Kota Nakamura; Shinsaku Obara; Hiromichi Kanehiro; Masayuki Sho
Journal:  World J Surg       Date:  2018-03       Impact factor: 3.352

4.  Predictors and outcome of complete removal of colorectal cancer with synchronous lung metastases.

Authors:  Hiroaki Nozawa; Junichiro Tanaka; Takeshi Nishikawa; Toshiaki Tanaka; Tomomichi Kiyomatsu; Kazushige Kawai; Keisuke Hata; Shinsuke Kazama; Hironori Yamaguchi; Soichiro Ishihara; Eiji Sunami; Joji Kitayama; Jun Nakajima; Norihiro Kokudo; Toshiaki Watanabe
Journal:  Mol Clin Oncol       Date:  2015-07-08

5.  A randomized controlled trial of surgery and postoperative modified FOLFOX6 versus surgery and perioperative modified FOLFOX6 plus cetuximab in patients with KRAS wild-type resectable colorectal liver metastases: EXPERT study.

Authors:  Masaru Matsumura; Kiyoshi Hasegawa; Masaru Oba; Kensei Yamaguchi; Hiroyuki Uetake; Takayuki Yoshino; Satoshi Morita; Keiichi Takahashi; Michiaki Unno; Yasuhiro Shimada; Kei Muro; Nobuhisa Matsuhashi; Masaki Mori; Hideo Baba; Mitsuo Shimada; Yoshihiro Mise; Yoshikuni Kawaguchi; Tatsuo Kagimura; Kiyoshi Ishigure; Akio Saiura; Kenichi Sugihara; Norihiro Kokudo
Journal:  Langenbecks Arch Surg       Date:  2022-02-25       Impact factor: 2.895

6.  Hepatectomy with Perioperative Chemotherapy for Multiple Colorectal Liver Metastases is the Available Option for Prolonged Survival.

Authors:  Kiyohiko Omichi; Yosuke Inoue; Yoshihiro Mise; Atsushi Oba; Yoshihiro Ono; Takafumi Sato; Hiromichi Ito; Yu Takahashi; Akio Saiura
Journal:  Ann Surg Oncol       Date:  2022-02-03       Impact factor: 5.344

7.  A postoperative scoring system for post-hepatectomy early recurrence of colorectal liver metastases.

Authors:  Rui Mao; Jian-Jun Zhao; Xin-Yu Bi; Ye-Fan Zhang; Zhi-Yu Li; Jian-Guo Zhou; Xiao-Long Wu; Chen Xiao; Hong Zhao; Jian-Qiang Cai
Journal:  Oncotarget       Date:  2017-09-15

Review 8.  Recurrence after hepatic resection in colorectal cancer liver metastasis -Review article-.

Authors:  B Lintoiu-Ursut; A Tulin; S Constantinoiu
Journal:  J Med Life       Date:  2015

9.  A 5-year recurrence-free survivor with over ten colorectal liver metastases undergoing FOLFOX plus bevacizumab followed by two-stage hepatectomy.

Authors:  Yuka Tamaoki; Toru Beppu; Yasuo Sakamoto; Katsunori Imai; Hiromitsu Hayashi; Hidetoshi Nitta; Daisuke Hashimoto; Yuji Miyamoto; Yutaka Tsuruta; Akira Chikamoto; Hideo Baba
Journal:  Surg Case Rep       Date:  2015-10-29

10.  FIRST BRAZILIAN CONSENSUS ON MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 1: PRE-TREATMENT EVALUATION.

Authors:  Felipe José Fernandez Coimbra; Heber Salvador de Castro Ribeiro; Márcio Carmona Marques; Paulo Herman; Rubens Chojniak; Antonio Nocchi Kalil; Evanius Garcia Wiermann; Sandro Roberto de Araújo Cavallero; Fabricio Ferreira Coelho; Paulo Henrique de Souza Fernandes; Anderson Arantes Silvestrini; Maria Fernanda Arruda Almeida; Antônio Luis Eiras de Araújo; Marcos Pitombo; Heberton Medeiros Teixeira; Fábio Luiz Waechter; Fábio Gonçalves Ferreira; Alessandro Landskron Diniz; Giuseppe D'Ippolito; Giuseppe D'Ippolito; Maria Dirlei F de Sousa Begnami; Gabriel Prolla; Silvio Márcio Pegoraro Balzan; Thiago Bueno de Oliveira; Luís Arnaldo Szultan; Javier Lendoire; Orlando Jorge Martins Torres
Journal:  Arq Bras Cir Dig       Date:  2015 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.